Doctor’s Guide -- CHICAGO -- October 12, 2010 -- A sizeable proportion of patients with advanced cancer and a life expectancy of only a few years continue to undergo common cancer screening tests that are unlikely to provide meaningful benefit, according to a study published in the October 13 issue of JAMA.
